Proprietary Name Acceptance Lettter - Corifact


Our STN: BL 125385/0                                                                                  

CSL Behring GmbH
Attention:  Mr. Paul R. Hartmann
1020 First Avenue, P.O. Box 61501 
King of Prussia, PA  19406-0901

Dear Mr. Hartmann:

We have reviewed your submission dated August 18, 2010 to your biologics license application (BLA) for Factor XIII Concentrate (Human) requesting a proprietary name review. 

In consultation with CBER’s Advertising and Promotional Labeling Branch (APLB) we conclude that under the Federal Food, Drug, and Cosmetic Act and applicable regulations, your proposed proprietary name, Corifact, is acceptable at this time.

If you have any questions, please contact Ms. Nannette Cagungun at (301) 827-6174.

Sincerely yours,

Basil Golding, M.D.
Director 
Division of Hematology
Office of Blood Research and Review
Center for Biologics 
Evaluation and Research
